Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). (Q44811925)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2004

Language	Label	Description	Also known as
English	Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).	scientific article published in March 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

circulatory system

1 reference

based on heuristic

inferred from title

Jeffrey A Johnson

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Scot H Simpson

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Rosemarie S Biggs

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ross T Tsuyuki

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

SCRIP Investigators

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

389-394

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Compliance with Clinical Practice Guidelines for Type 2 Diabetes in Rural Patients: Treatment Gaps and Opportunities for Improvement

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

A multivariate analysis of the risk of coronary heart disease in Framingham

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Mortality rates in diabetic patients from a community-based population compared to local age/sex matched controls

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Patient-perceived barriers to preventive health care among indigent, rural Appalachian patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.4.389.33169

21 January 2018

Identifiers

10.1592/PHCO.24.4.389.33169

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44811925&oldid=1230767877"